Adequacy of anticoagulation in patients with atrial fibrillation: Effect of various parameters

Clinical Cardiology

Volumn 24, Issue 5, 2001, Pages 380-384

  Cohen, Natan ^a   Almoznino Sarafian, Dorit ^a   Alon, Irena ^a   Gorelik, Oleg ^a   Koopfer, Margarita ^a   Chachashvily, Shulamit ^a   Shteinshnaider, Miriam ^a   Litvinjuk, Vladimir ^a   Modai, David ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anticoagulation; Atrial fibrillation; Follow up; International Normalized Ratio control; Stroke

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CONGESTIVE HEART FAILURE; DOCTOR PATIENT RELATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; HUMAN TISSUE; INTERNATIONAL STANDARD UNIT; ISRAEL; MAJOR CLINICAL STUDY; MALE; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FEMALE; GUIDELINE ADHERENCE; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MULTIVARIATE ANALYSIS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0035032093     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240507     Document Type: Article

References (25)

1. Antithrombotic therapy in atrial fibrillation
2. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
3. Atrial fibrillation and thromboembolism: A decade of progress in stroke prevention
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
5. Recent national patterns of warfarin use in atrial fibrillation
6. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation
7. Is warfarin underused in the treatment of elderly persons with atrial fibrillation?
8. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals
9. Population based study of use of anticoagulants among patients with atrial fibrillation in the community
10. Treatment of atrial fibrillation in a district general hospital
11. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospital
12. Thromboembolism in chronic atrial flutter: Is the risk underestimated?
13. Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic
14. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting
15. Comparison of an anticoagulation clinic with usual medical care
16. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation
17. Anticoagulation control with warfarin by junior hospital doctors
18. Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice?
19. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomized clinical trial. Stroke prevention in atrial fibrillation investigators
20. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
21. Update in general internal medicine. Anticoagulation and atrial fibrillation
22. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves
23. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy
24. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial
25. Oral anticoagulation: Improving the risk-benefit ratio